Clinical Trial Update: Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing tiotropium bromide alone versus tiotropium bromide with formoterol fumarate in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Foradil (formoterol)
• Spiriva (tiotropium)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED